{
  "docId": "019de071-1981-7442-94ed-ee285d10f59b",
  "docSlug": "c18efbd116f640ca1060cd96d0c18250",
  "documentTitle": "Alkermes | Results Presentation Deck | 31 slides",
  "authorId": "alkermes",
  "authorName": "Alkermes",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 26,
  "pageCount": 31,
  "prevPage": 25,
  "nextPage": 27,
  "slideType": "key_takeaways",
  "function": "analyze_data",
  "density": "overcrowded",
  "nDataPoints": 12,
  "notes": "Includes both longitudinal line charts and bar charts for maximum fold change.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-1981-7442-94ed-ee285d10f59b/26",
  "deckHref": "/decks/019de071-1981-7442-94ed-ee285d10f59b",
  "deckJsonHref": "/decks/019de071-1981-7442-94ed-ee285d10f59b.json",
  "deckAnchorHref": "/decks/019de071-1981-7442-94ed-ee285d10f59b#slide-26",
  "components": [
    {
      "bbox": {
        "h": 0.3,
        "w": 0.5,
        "x": 0.05,
        "y": 0.55
      },
      "kind": "chart",
      "text": "Maximum fold change comparison",
      "attrs": null,
      "subkind": "bar-grouped",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b2fcd9c6-ef6f-4cb4-a36b-063673fd3f8e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.5,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "chart",
      "text": "Longitudinal immune cell expansion",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "99e6d55d-8eb2-4416-bb5d-307d3e84da4d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.38,
        "x": 0.58,
        "y": 0.2
      },
      "kind": "list",
      "text": "3 mg q7d SC nemvaleukin provided greater expansion of CD8+ T cells and NK cells relative to IV nemvaleukin; NK cells are known to play a key role in tumor cell killing",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f5c68564-c6ea-4bdd-b44f-6844d896951b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.38,
        "x": 0.58,
        "y": 0.45
      },
      "kind": "paragraph",
      "text": "Initial anti-tumor activity observed in dose escalation cohorts: Of 57 patients with >= 1 on-treatment scans, 31 (54%) had stable disease on first scan; Of 37 patients with >= 2 on-treatment scans, 17 (46%) had stable disease on 2 or more consecutive scans",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "46193a82-eb66-43d4-90b3-a4327af5b4fd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "1. Wu, SY., Fu, T., Jiang, YZ. et al. Natural killer cells in cancer biology and therapy. Mol Cancer 19, 120 (2020). Data cut off March 19, 2021",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7f642828-81cd-4f67-ba6c-3dc4a372c272",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "SC Nemvaleukin Selectively Expanded Circulating NK and CD8+ T Cells, and Demonstrated Initial Anti-Tumor Activity",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "896041e7-5088-4a81-8f13-0af26c6961f7",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "2x2 matrix",
      "slug": "matrix-2x2",
      "agent": null,
      "layer": "slide",
      "matchId": "6ce7ab2a-457c-4b52-b8ac-1404b3acec06",
      "evidence": "Although not explicitly a 2x2 matrix, the comparison of SC nemvaleukin and IV nemvaleukin in terms of immune cell expansion could be argued to approach a 2x2 matrix-like structure.",
      "confidence": 0.5
    },
    {
      "name": "Data Story Arc",
      "slug": "data-story-arc",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "e3259274-e670-4203-ac60-9c14b372b59d",
      "evidence": "The slide presents data on the selective expansion of immune cells and early signs of anti-tumor efficacy, creating a narrative around the data.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 31,
      "from": 22,
      "beatId": "6729dbcf-9af8-4183-a612-b8bbf1c1b0a8",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Impact & Next Steps",
      "beatSlug": "consultants-gambit-impact-next-steps",
      "evidence": "The presentation concludes with a summary of results and a panel discussion",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}